Continuous Monitoring of Cerebral Autoregulation in Adults Supported by Extracorporeal Membrane Oxygenation.

ECMO Extracorporeal membrane oxygenation cerebral autoregulation near-infrared spectroscopy neurological outcomes optimal perfusion pressure

Journal

Research square
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035

Informations de publication

Date de publication:
21 Sep 2023
Historique:
pubmed: 4 10 2023
medline: 4 10 2023
entrez: 4 10 2023
Statut: epublish

Résumé

Impaired cerebral autoregulation (CA) is one of several proposed mechanisms of acute brain injury in patients supported by extracorporeal membrane oxygenation (ECMO). The primary aim of this study was to determine the feasibility of continuous CA monitoring in adult ECMO patients. Our secondary aims were to describe changes in cerebral oximetry index (COx) and other metrics of CA over time and in relation to functional neurologic outcomes. This is a single-center prospective observational study. We measured Cox, a surrogate measurement of cerebral blood flow, measured by near-infrared spectroscopy, which is an index of CA derived from the moving correlation between mean arterial pressure and slow waves of regional cerebral oxygen saturation. A COx value that approaches 1 indicates impaired CA. Using COx, we determined the optimal MAP (MAP Fifteen patients (median age=57 years [IQR=47-69]) with 150 autoregulation measurements were included for analysis. Eleven were on veno-arterial ECMO and 4 on veno-venous. Mean COx was higher on post-cannulation day 1 than on day 2 (0.2 vs 0.09, In ECMO patients, it is feasible to monitor CA continuously at the bedside. CA improved over time, most significantly between post-cannulation days 1 and 2. CA was more impaired in VA-ECMO than VV-ECMO. Spending less time outside of MAP

Sections du résumé

Background UNASSIGNED
Impaired cerebral autoregulation (CA) is one of several proposed mechanisms of acute brain injury in patients supported by extracorporeal membrane oxygenation (ECMO). The primary aim of this study was to determine the feasibility of continuous CA monitoring in adult ECMO patients. Our secondary aims were to describe changes in cerebral oximetry index (COx) and other metrics of CA over time and in relation to functional neurologic outcomes.
Methods UNASSIGNED
This is a single-center prospective observational study. We measured Cox, a surrogate measurement of cerebral blood flow, measured by near-infrared spectroscopy, which is an index of CA derived from the moving correlation between mean arterial pressure and slow waves of regional cerebral oxygen saturation. A COx value that approaches 1 indicates impaired CA. Using COx, we determined the optimal MAP (MAP
Results UNASSIGNED
Fifteen patients (median age=57 years [IQR=47-69]) with 150 autoregulation measurements were included for analysis. Eleven were on veno-arterial ECMO and 4 on veno-venous. Mean COx was higher on post-cannulation day 1 than on day 2 (0.2 vs 0.09,
Conclusions UNASSIGNED
In ECMO patients, it is feasible to monitor CA continuously at the bedside. CA improved over time, most significantly between post-cannulation days 1 and 2. CA was more impaired in VA-ECMO than VV-ECMO. Spending less time outside of MAP

Identifiants

pubmed: 37790309
doi: 10.21203/rs.3.rs-3300834/v1
pmc: PMC10543291
pii:
doi:

Types de publication

Preprint

Langues

eng

Déclaration de conflit d'intérêts

Potential Conflict of Interests Vishank A. Shah, MBBS serves on Editorial Board of Neurohospitalist and received personal fees of less than $1000 from AstraZeneca. All other authors have no conflicts of interests to declare.

Auteurs

Lucy Q Zhang (LQ)

Johns Hopkins School of Medicine: The Johns Hopkins University School of Medicine.

Henry Chang (H)

Johns Hopkins School of Medicine: The Johns Hopkins University School of Medicine.

Andrew Kalra (A)

Johns Hopkins School of Medicine: The Johns Hopkins University School of Medicine.

Mariyam Humayun (M)

Johns Hopkins School of Medicine: The Johns Hopkins University School of Medicine.

Kathryn R Rosenblatt (KR)

Johns Hopkins School of Medicine: The Johns Hopkins University School of Medicine.

Vishank A Shah (VA)

Johns Hopkins School of Medicine: The Johns Hopkins University School of Medicine.

Romergryko G Geocadin (RG)

Johns Hopkins School of Medicine: The Johns Hopkins University School of Medicine.

Charles H Brown (CH)

Johns Hopkins School of Medicine: The Johns Hopkins University School of Medicine.

Bo Soo Kim (BS)

Johns Hopkins School of Medicine: The Johns Hopkins University School of Medicine.

Glenn J R Whitman (GJR)

Johns Hopkins School of Medicine: The Johns Hopkins University School of Medicine.

Lucia Rivera-Lara (L)

Stanford University Department of Neurology and Neurological Sciences.

Sung-Min Cho (SM)

Johns Hopkins Department of Anesthesiology and Critical Care Medicine: Johns Hopkins Medicine Department of Anesthesiology and Critical Care Medicine.

Classifications MeSH